Tecnigen Italy, a subsidiary of the Tecnimede Group, began trading in the Italian pharmaceutical industry in 2014.
With a focus on generic drugs, Tecnigen Italia covers the main therapeutic areas of the generic pharmaceutical market. Most of the products are the result of its own research, development, and production, thanks to the Research and Development centre, Labor Qualitas, and the Atlantic Pharma production centre, which is dedicated to the production of medicines for human use.
Tecnigen's presence in Italy has been going from strength to strength, first with the launch of a range of over-the-counter medicines and then with the launch of a range of dietary supplements.
Tecnigen Italy aims to continue to invest in healthcare through new developments and diversification within the Italian pharmaceutical industry.
